Federal Open Market Committee; Domestic Policy Directive of February 1-2, 2005, 11245 [05-4455]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 44 / Tuesday, March 8, 2005 / Notices
1. Exchange National Bancshares,
Inc., Jefferson City, Missouri; to acquire
100 percent of the voting shares of Bank
10, Belton, Missouri.
2. First National Security Company,
DeQueen, Arkansas; to acquire 100
percent of the voting shares of First
Community Banking Corporation, Hot
Springs, Arkansas, and thereby
indirectly acquire First National Bank,
Hot Springs, Arkansas; First National
Bank in Mena, Mena, Arkansas; and
First National Bank, Mount Ida,
Arkansas.
Board of Governors of the Federal Reserve
System, March 2, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–4456 Filed 3–7–05; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL RESERVE SYSTEM
Federal Open Market Committee;
Domestic Policy Directive of February
1-2, 2005
In accordance with § 271.25 of its
rules regarding availability of
information (12 CFR part 271), there is
set forth below the domestic policy
directive issued by the Federal Open
Market Committee at its meeting held
on February 1-2, 2005.1
The Federal Open Market Committee
seeks monetary and financial conditions
that will foster price stability and
promote sustainable growth in output.
To further its long–run objectives, the
Committee in the immediate future
seeks conditions in reserve markets
consistent with increasing the federal
funds rate to an average of around 2-1/
2 percent.
By order of the Federal Open Market
Committee, February 28, 2005.
Vincent R. Reinhart,
Secretary, Federal Open Market Committee.
[FR Doc. 05–4455 Field 3–7–05; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Limited Competition for Supplemental
Grants for Centers for Education and
Research (CERTs)
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice of availability of fund for
limited competitive supplements.
AGENCY:
SUMMARY: This notice informs the
research community that the Agency for
Healthcare Research and Quality
(AHRQ) is requesting applications for
competitive supplemental grants from
the seven Centers for Education and
Research on Therapeutics (CERTs) for
which it provided funding in fiscal year
2004.
The purpose of the competitive
supplements is to provide funds for
existing CERTs research centers to build
on and to expand their research work
and expertise with respect to
comparative effectiveness research
specifically to carry out short term
projects that will address research gaps
in priority subject areas identified and
published pursuant to section 1013 of
the Medicare Prescription Drug,
Improvement, and Modernization Act
(MMA). Since the inception of the
CERTs program in 1999, the CERTs
research centers have gathered
significant data regarding therapeutics,
refined research methodologies, and
developed collaborative research
resources. They are therefore uniquely
prepared and suited to efficiently carry
out pharmaco-epidemiology and
methodological studies related to
comparative effectiveness research that
is pertinent to developing therapeutic
evidence identified as being of high
interest to the Medicare, Medicaid or
SCHIP programs. For this reason, this
solicitation will be for a limited
competition among CERTs grantees.
DATES: The receipt date for the
competitive supplemental grant
applications is April 7, 2005. AHRQ
will inform the current grantees directly
regarding application procedures and
format.
Submission of the
applications should be sent to: Dr.
Gerald Calderone, Office of Extramural
Research, Education, and Priority
Populations, Agency for Healthcare
Research and Quality, 540 Gaither Road,
Rockville, MD 20850, Phone: (301) 427–
1548, Fax: (301) 427–1561, E-mail:
gcaldero@ahrq.gov.
ADDRESSES:
1 Copies of the Minutes of the Federal Open
Market Committee meeting on February 1-2, 2005,
which includes the domestic policy directive issued
at the meeting, are available upon request to the
Board of Governors of the Federal Reserve System,
Washington, D.C. 20551. The minutes are published
in the Federal Reserve Bulletin and in the Board’s
annual report.
VerDate jul<14>2003
19:54 Mar 07, 2005
Jkt 205001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
11245
Dr.
Scott R. Smith, Center for Outcomes and
Evidence, Agency for Healthcare
Research and Quality, 540 Gaither Road,
Rockville, MD 20850, Phone: (301) 427–
1511, Fax: (301) 427–1520, E-mail:
ssmith@ahrq.gov.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Background
Section 1013 of the MMA directs the
Secretary of the Department of health
and Human Services (DHHS), acting
through the Director of AHRQ, to
support research to address priorities
identified by the Medicare, Medicaid,
and SCHIP programs and other
concerned stakeholders, regarding
improvement of health care outcomes,
comparative clinical effectiveness, and
appropriateness of health care items and
services (including prescription drugs)
either provided or possibly not
currently covered under these programs;
and strategies for improving program
efficiency and effectiveness with
attention to the ways in which health
care items and services are organized,
managed, and delivered under these
programs.
Pursuant to this section 1013, which
may also be found at 42 U.S.C. 229b–7,
DHHS published, on December 15,
2004, an initial priority list of ten
conditions with respect to which
research mandated under this section is
to be promptly undertaken. The ten
conditions are:
• Ischemic heart disease
• Cancer
• Chronic obstructive pulmonary
disease/asthma
• Stroke, including control of
hypertension
• Arthritis and non-traumatic joint
disorders
• Diabetes mellitus
• Dementia, including Alzheimer’s
disease
• Pneumonia
• Peptic ulcer/dyspepsia
• Depression and other mood
disorders
The Centers for Education and
Research on Therapeutics (CERTs)
program was first developed by AHRQ
in accordance with a Congressional
authorization in the Food and Drug
Administration Modernization Act of
1997 (Pub. L. 105–115) to carry out or
support research that would provide
objective information on drugs,
biologics, and medical devices. Just
months after the first CERTs grants were
awarded, the CERTs program was
incorporated into the AHRQ
Reauthorization Act of 1999 (Pub. L.
106–129); its objectives: to increase
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 70, Number 44 (Tuesday, March 8, 2005)]
[Notices]
[Page 11245]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4455]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Federal Open Market Committee; Domestic Policy Directive of
February 1-2, 2005
In accordance with Sec. 271.25 of its rules regarding availability
of information (12 CFR part 271), there is set forth below the domestic
policy directive issued by the Federal Open Market Committee at its
meeting held on February 1-2, 2005.\1\
---------------------------------------------------------------------------
\1\ Copies of the Minutes of the Federal Open Market Committee
meeting on February 1-2, 2005, which includes the domestic policy
directive issued at the meeting, are available upon request to the
Board of Governors of the Federal Reserve System, Washington, D.C.
20551. The minutes are published in the Federal Reserve Bulletin and
in the Board's annual report.
---------------------------------------------------------------------------
The Federal Open Market Committee seeks monetary and financial
conditions that will foster price stability and promote sustainable
growth in output. To further its long-run objectives, the Committee in
the immediate future seeks conditions in reserve markets consistent
with increasing the federal funds rate to an average of around 2-1/2
percent.
By order of the Federal Open Market Committee, February 28, 2005.
Vincent R. Reinhart,
Secretary, Federal Open Market Committee.
[FR Doc. 05-4455 Field 3-7-05; 8:45 am]
BILLING CODE 6210-01-S
